BioVie
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioVie and other ETFs, options, and stocks.About BIVI
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
CEOCuong Viet Do
CEOCuong Viet Do
Employees13
Employees13
HeadquartersCarson City, Nevada
HeadquartersCarson City, Nevada
Founded2013
Founded2013
Employees13
Employees13
BIVI Key Statistics
Market cap9.27M
Market cap9.27M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume117.77K
Average volume117.77K
High today$1.30
High today$1.30
Low today$1.21
Low today$1.21
Open price$1.25
Open price$1.25
Volume81.80K
Volume81.80K
52 Week high$22.90
52 Week high$22.90
52 Week low$1.10
52 Week low$1.10
Stock Snapshot
As of today, BioVie(BIVI) shares are valued at $1.27. The company's market cap stands at 9.27M, with a P/E ratio of -0.14.
As of 2026-01-14, BioVie(BIVI) stock has fluctuated between $1.21 and $1.30. The current price stands at $1.27, placing the stock +5.0% above today's low and -2.3% off the high.
The BioVie(BIVI)'s current trading volume is 81.8K, compared to an average daily volume of 117.77K.
In the last year, BioVie(BIVI) shares hit a 52-week high of $22.90 and a 52-week low of $1.10.
In the last year, BioVie(BIVI) shares hit a 52-week high of $22.90 and a 52-week low of $1.10.
BIVI News
TipRanks 7d
BioVie completes enrollment in Phase 2 SUNRISE-PD trialBioVie (BIVI) completed enrollment of 60 patients in its Phase 2 SUNRISE-PD clinical trial evaluating the safety and efficacy of bezisterim on motor and non-mot...
People also own
Based on the portfolios of people who own BIVI. This list is generated using Robinhood data, and it’s not a recommendation.